EDI
-
Burgopak launch Chrysalis Carton in partnership with Medica Packaging
The solution connects the outer carton and patient information leaflet (PIL) conveniently together. The patient pulls a perforated flap on the carton to expose the patient leaflet, which they can unfold to display the product information.
EDI | 21 May 2012
-
Telormedix’s TMX-101 exhibits high safety in phase I/II for non-muscle invasive bladder cancer
Telormedix announced that it has successfully completed the safety portion of a Phase I/II trial for TMX-101.
EDI | 04 May 2012
-
More investment needed in anti-obesity drugs
Pharmaceutical companies should increase their investment in anti-obesity drug therapies to support the growing number of clinically obese individuals worldwide, a report by GlobalData has found.
EDI | 01 May 2012
-
Merck donates five mobile compact labs for detecting counterfeit medicines to Zambia
To help improve health care in Zambia, the Global Pharma Health Fund, a charitable initiative funded by Merck, has donated five mobile compact laboratories to the Health Ministry in the capital city of Lusaka to help detect counterfeit medicines.
EDI | 24 April 2012
-
Erasmus Medical Center selects Agilent solutions
Agilent Technologies announced that Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part of the Erasmus Rucphen Family study to identify genetic risk factors for some complex genetic disorders.
EDI | 23 April 2012
-
Espicom predicts new novel approaches to the treatment of cancer will be launched by 2018
According to an Espicom report, Targeted Cancer D: The launch landscape to 2018,the global cancer market could be set for rapid growth in key sectors, driven by increasingly un-met clinical need and the introduction of new drugs which effectively target new pathways.
EDI | 29 March 2012
-
JSR expands biomedical business
JSR Corporation and BIA Separations announced that they have entered a partnership which includes a minor equity position by JSR.
EDI | 29 February 2012
-
Genetic Technologies receives CLIA certificate of compliance from Centers for Medicare and MedicAid Services, USA
Genetic Technologies announced that it has received the Certificate of Compliance for its Australian laboratory under the US Clinical Laboratories Improvements Amendments (CLIA) regulations as administered by the Centers for Medicare and Medicaid Services (CMS).
EDI | 21 February 2012
-
Telormedix secures further funding
Telormedix announced that it has raised 7.5 million CHF (US$8.1 million) from existing investors Aravis Venture and Proquest Investments.
EDI | 17 February 2012
-
Life Technologies appoints president of medical sciences
Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.
EDI | 10 February 2012
